BackSingular Genomics Systems Overview

Singular Genomics Systems Current Cash

Singular Genomics Systems's current cash is $53M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$52.62M
↑ 58.01% YoYΔ $19.32M vs prior year quarter

Peer trimmed avg / median

Loading

Singular Genomics Systems Current Cash History

Loading

Singular Genomics Systems vs. peers: Current Cash Comparison

Loading

Singular Genomics Systems Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Singular Genomics Systems (OMIC) FAQ

The latest current cash for OMIC is $53M as of September 2024. That compares with $33M in the prior-year period — up 58.0% year over year. Investors often review this figure alongside Singular Genomics Systems's historical trend and sector peers before judging valuation or financial health.

Over the past year, OMIC's current cash moved from $33M to $53M — a 58.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Singular Genomics Systems's operating scale or balance-sheet position.

A current cash figure of $53M for OMIC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OMIC's current cash ($53M), review year-over-year change from $33M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Singular Genomics Systems's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.